Haoxi Health Technology CFO Resigns
Ticker: HAO · Form: 6-K · Filed: Sep 25, 2024 · CIK: 1954594
| Field | Detail |
|---|---|
| Company | Haoxi Health Technology LTD (HAO) |
| Form Type | 6-K |
| Filed Date | Sep 25, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: cfo-change, resignation
TL;DR
Haoxi Health's CFO, Bo Lv, is out as of 9/25/24 for personal reasons.
AI Summary
On September 25, 2024, Haoxi Health Technology Limited announced that its Chief Financial Officer, Mr. Bo Lv, has resigned from his position due to personal reasons. The company has not disclosed any disagreements with Mr. Lv regarding his departure.
Why It Matters
A change in CFO can signal shifts in financial strategy or internal stability, potentially impacting investor confidence and the company's stock performance.
Risk Assessment
Risk Level: medium — CFO resignations can indicate underlying issues within a company's financial management or strategic direction, warranting closer investor scrutiny.
Key Players & Entities
- Haoxi Health Technology Limited (company) — The company filing the report.
- Bo Lv (person) — Resigning Chief Financial Officer.
- September 25, 2024 (date) — Effective date of resignation.
FAQ
Who is replacing Bo Lv as CFO?
The filing does not state who will replace Bo Lv as CFO.
What are the specific personal reasons for Bo Lv's resignation?
The filing states Mr. Bo Lv's resignation was due to personal reasons but does not provide specific details.
Are there any disagreements between Bo Lv and the Company?
No, Mr. Bo Lv has advised the Company that his resignation was not a result of any disagreement with the Company.
When was Bo Lv's resignation effective?
Mr. Bo Lv's resignation was effective as of September 25, 2024.
What is Haoxi Health Technology Limited's primary business?
Haoxi Health Technology Ltd is listed under SERVICES-ADVERTISING AGENCIES [7311].
Filing Stats: 413 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-09-25 16:05:15
Filing Documents
- ea0215582-6k_haoxi.htm (6-K) — 11KB
- 0001213900-24-081796.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Haoxi Health Technology Limited Date: September 25, 2024 By: /s/ Zhen Fan Name: Zhen Fan Title: Chief Executive Officer 2